decide Clinical Software develops and provides AI-driven, safe, fast and evidence-based dosing of insulin at the point of care for seriously ill inpatients via our Clinical Decision Support System GlucoTab.
R&D:Clinical Decision Support with the focus on the chronic disease diabetes in different settings (acute care, nursing homes, ambulance care, self-management)
Production:Our Clinical Decision Support System GlucoTab supports the blood sugar management of hospitalized patients with diabetes at the “point of care” (PoC). For patients with type 2 diabetes, automated suggestions for insulin dosing are calculated using clinically validated algorithms and suggested to users (medical and nursing staff). Furthermore, GlucoTab supports the workflow of diabetes therapy and enables the prescription and documentation for all patients for both insulin and other blood sugar-l
Sales/Distribution:decide is interested in distributors, implementation partners and hospitals seeking an innovative system for treating patients with diabetes. decide is a research-oriented company and is also interested in cooperation partners in the fields of decision-making support and diabetes management.
Neue Stiftingtalstraße 2
8010 Graz
Styria
Contact: Andreas Krug (Geschäftsführer)
Email: office@glucotab.at
Website